10-87709326-CAT-C
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_001015880.2(PAPSS2):c.145+31_145+32delTA variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0323 in 1,092,236 control chromosomes in the GnomAD database, including 10 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0049 ( 9 hom., cov: 0)
Exomes 𝑓: 0.037 ( 1 hom. )
Consequence
PAPSS2
NM_001015880.2 intron
NM_001015880.2 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.0260
Genes affected
PAPSS2 (HGNC:8604): (3'-phosphoadenosine 5'-phosphosulfate synthase 2) Sulfation is a common modification of endogenous (lipids, proteins, and carbohydrates) and exogenous (xenobiotics and drugs) compounds. In mammals, the sulfate source is 3'-phosphoadenosine 5'-phosphosulfate (PAPS), created from ATP and inorganic sulfate. Two different tissue isoforms encoded by different genes synthesize PAPS. This gene encodes one of the two PAPS synthetases. Defects in this gene cause the Pakistani type of spondyloepimetaphyseal dysplasia. Two alternatively spliced transcript variants that encode different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 10-87709326-CAT-C is Benign according to our data. Variant chr10-87709326-CAT-C is described in ClinVar as [Benign]. Clinvar id is 1599026.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr10-87709326-CAT-C is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00492 (736/149486) while in subpopulation AFR AF= 0.015 (614/40840). AF 95% confidence interval is 0.0141. There are 9 homozygotes in gnomad4. There are 331 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 9 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAPSS2 | NM_001015880.2 | c.145+31_145+32delTA | intron_variant | ENST00000456849.2 | NP_001015880.1 | |||
PAPSS2 | NM_004670.4 | c.145+31_145+32delTA | intron_variant | NP_004661.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PAPSS2 | ENST00000456849.2 | c.145+31_145+32delTA | intron_variant | 1 | NM_001015880.2 | ENSP00000406157.1 | ||||
PAPSS2 | ENST00000361175.8 | c.145+31_145+32delTA | intron_variant | 1 | ENSP00000354436.4 | |||||
PAPSS2 | ENST00000465996.5 | n.167+31_167+32delTA | intron_variant | 2 | ||||||
PAPSS2 | ENST00000482258.1 | n.188+31_188+32delTA | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00492 AC: 735AN: 149378Hom.: 9 Cov.: 0
GnomAD3 genomes
AF:
AC:
735
AN:
149378
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0366 AC: 34489AN: 942750Hom.: 1 AF XY: 0.0370 AC XY: 17907AN XY: 483806
GnomAD4 exome
AF:
AC:
34489
AN:
942750
Hom.:
AF XY:
AC XY:
17907
AN XY:
483806
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00492 AC: 736AN: 149486Hom.: 9 Cov.: 0 AF XY: 0.00454 AC XY: 331AN XY: 72926
GnomAD4 genome
AF:
AC:
736
AN:
149486
Hom.:
Cov.:
0
AF XY:
AC XY:
331
AN XY:
72926
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Spondyloepimetaphyseal dysplasia, PAPSS2 type Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at